Skip to main content
SpringerLink
Log in

Immunomonitoring followed by optimal dec therapy for successful management of clinical filariasis in an endemic area

  • Reviews
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Lymphatic filariasis continues to be the major cause of clinical morbidity in India and other developing tropical countries. One of the major lacunae in the effective management of clinical filarial cases is the non-availability of a suitable diagnostic test for confirming filaria aetiology in acute, chronic and occult clinical cases where microfilariae (mf) are not usually seen in peripheral circulation. Studies in our laboratory have shown the usefulness of filarial antibody and antigen assays using microfilarial excretory-secretory (mf ES) antigen in detecting microfilaraemic, acute and chronic filarial cases and in confirming filarial aetiology in occult infections. Diethylcarbamazine citrate (DEC) is the drug of choice for lymphatic filariasis. Different regimens of DEC have been explored in the treatment of microfilaraemic cases. Immunomonitoring has shown that the seroconversion of antigen and antibody positivity was found to be very helpful in determining appropriate period of DEC treatment for clinical relief and cure in clinical filarial patients and further they did not have recurrence in most of the cases. Optimal DEC (6mg/kg body wt/day for 21 days each month for 3–12 months) therapy was found to be very effective in acute and atypical clinical manifestations such as asthmatic bronchitis, pulmonary eosinophilia, monoarthritis, recurrent upper respiratory tract infections (URI), pneumonia (super imposed infections) in children and minimal hydrocele, epididymoorchitis, lymphangitis, lymphadenitis, acute abdomen, central serous retinopathy, tenosynovitis, pain and swelling in limbs and joints in adults living in filaria endemic areas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. (1994) Lymphatic filariasis Infection & Disease Control Strategies: Report of a WHO/CTD/TDR consultative meeting. 1.

  2. Sharma, R.S. (1996) Filariasis problem in India and the current control strategy. In: NICD (Ed). Revised strategy for control of lymphatic filariasis in India. NICD: Delhi. 10.

    Google Scholar 

  3. Harinath, B.C., Malhotra, A., Ghimikar, S.N., Annadate, S.D., Issacs, V.P. and Bharati, M.S. (1984) Field evaluation of an enzyme immunosorbent assay usingWuchereria bancrofti mf ES antigen for bancroftian filariasis. Bull WHO. 62, 941–44.

    PubMed  CAS  Google Scholar 

  4. Alikhan, A., Parkhe, K.A., Reddy, M.V.R. and Harinath, B.C. (1990) Filarial antigen antibody and circulating immune—complexed antigen levels in bancroftian filariasis by stick ELISA. Natl. Med. J. India. 3, 265–68.

    Google Scholar 

  5. Harinath, B.C. and Reddy, M.V.R. (1997) Diagnosis and immunomonitoring in the successful management of bancroftian filariasis. J. Parasitic. Dis. 21, 41–51.

    Google Scholar 

  6. Patond, K.R., Tandon, V., Harinath, B.C., Narang, P., Srivastava, S.K., Cheirmaraj, K. and Ramarao, B.V. (1992) A clinico epidemiological study of filarial related orthopaedic manifestations Ind. J. Com. Med. 17, 98–101.

    Google Scholar 

  7. Chaturvedi, P., Gawdi, A. and Dey, S. (1990) Occult filariasis infection. Natl. Med. J. India. 3, 7–9.

    Google Scholar 

  8. Chaturvedi, P., Harinath, B.C., Reddy, M.V.R., Advani, B., Gawdi, A., Alikhan, A. and Ramarao, B.V. (1995) Filarial antibody detection in suspected occult filariasis in children in an endemic area. J. Trop. Paed. 41, 243–245.

    CAS  Google Scholar 

  9. Reddy, M.V.R., Alli, R., Devi, K.K., Narayan, R., Harikrishnan, R., Cheirmaraj, K. and Harinath, B.C. (1996) Comparative evaluation of microtitre plate peroxidase and stick penicillinase enzyme immunoassays for detection of filarial antibodies usingBrugia malayi microfilarial excretory-secretory antigen. J. Parasitic. Dis. 20, 173–176.

    CAS  Google Scholar 

  10. Lalitha, P., Ravichandran, M., Suba, S., Kaliraj, P., Narayanan, R.B. and Jayaraman, K. (1998) Quantitative assessment of circulating antigens in human lymphatic filariasis: a field evaluation of monoclonal antibody based ELISA using blood collected on filter strips. Trop. Med. Int. Health. 3, 41–45.

    Article  PubMed  CAS  Google Scholar 

  11. Dreyer, G., Amaral, F., Noroes, J., Medeiros, Z. and Addiss, D. (1995) A new tool to assess the adulticidal efficacyin vivo of antifilarial drugs for bancrftian filariasis. Trans. Roy. Soc. Trop. Med. Hyg. 89, 225–226.

    Article  PubMed  CAS  Google Scholar 

  12. Malhotra, A. and Harinath, B.C. (1984) Detection and monitoring of microfilarial ES antigen levels by inhibition ELISA during DEC therapy. Ind. J. Med. Res. 79, 194–198.

    CAS  Google Scholar 

  13. Ramaprasad, P., Prasad, G.B.K.S. and Harinath, B.C. (1988) Microfilariaemia filarial antibody antigen and immunecomplex levels in human filariasis before, during and after DEC therapy. Acta. Tropica. 45, 245–255.

    PubMed  CAS  Google Scholar 

  14. Lammie, P.J., Eberhard, M.L., Leiva, L.E., Lowrie, R.C.J. and Katz., S.P. (1988) The effect of diethylcarbamazine treatment of bancroftian filariasis on the immunological reactivity of microfilaraemic individuals. Trans. Roy. Soc. Trop. Med. Hyg. 82, 726–729.

    Article  PubMed  CAS  Google Scholar 

  15. Zheng, H.J., Piessens, W.F., Tao, Z., Cheng, W., Wang, S. Cheng, S. Ye, Y., Luo, L., Chen, X., Gan, G. and Piessens, W.F. (1991) Efficacy of ivermectin for control of microfilaraemia recurring after treatment with diethylcarbamazine II. Immunological changes following treatment. Am. J. Trop. Med. Hyg. 45, 175–181.

    PubMed  CAS  Google Scholar 

  16. Day, K.P, Spark, R., Garner, P., Raiko, A., Wenger, J.D., Weiss, N. Michell, G.F., Albar, M.P. and Kazura, J.N. (1991) Serological evaluation of the macrofilariacidal effects of diethylcarbamazine treatment in bancroftian filariasis. Am. J. Trop. Med. Hyg. 44, 528–535.

    PubMed  CAS  Google Scholar 

  17. Kurniawan, A., Atkinson, R., Sartono, E., Partono, F., Yazdanbaksh, M. and Maizels, R. M. (1995) Differential decline of filaria specific IgG1, IgG4 and IgE antibodies inBrugia malayi infected patients after diethyl carbamazine chemotherapy. J. Inf. Dis. 172, 1567–1572.

    Google Scholar 

  18. Padigel, U.M., Reddy, M.V.R., Alikhan, A. and Harinath, B.C. (1995) Immunomonitoring of filarial patients during DEC therapy in an endemic area: a seven year follow up. J Trop. Med. Hyg. 98, 52–56.

    PubMed  CAS  Google Scholar 

  19. Harinath, B.C., Padigel, U.M., Devi, K.K. and Reddy, M.V.R. (1996) Diagnosis and immunomonitoring in management of filariasis in an endemic area. J. Parasitic. Dis. 20, 35–40.

    Google Scholar 

  20. World Health Organization. In: Lymphatic filariasis: (1992) The Disease and its control (Fifth report of the WHO Expert working Committee on Filariasis). WHO. Tech. Rep. Ser. 821, 43–44.

    Google Scholar 

  21. Harinath, B.C., Satish Kumar. and Reddy, M.V.R. (1997)In vitro released antigens in diagnosis and immunomonitoring of filaria and tuberculosis. Ind. J. Clin. Biochem. 12 (Suppl), 8–12.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, 442 102, Wardha, India

    B. C. Harinath (Director-Professor & Head), M. V. R. Reddy & R. Alli

  2. Department of Surgery, Mahatma Gandhi Institute of Medical Sciences, Sevagram, 442 102, Wardha, India

    V. K. Mehta

  3. Department of Paediatrics, Mahatma Gandhi Institute of Medical Sciences, Sevagram, 442 102, Wardha, India

    P. Chaturvedi

  4. Department of Orthopaedics, Mahatma Gandhi Institute of Medical Sciences, Sevagram, 442 102, Wardha, India

    K. R. Patond

  5. Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram, 442 102, Wardha, India

    S. P. Kalantri

  6. Department of Community Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram, 442 102, Wardha, India

    R. K. C. Gupta

Authors
  1. B. C. Harinath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. V. R. Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Alli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. K. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Chaturvedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. R. Patond
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. P. Kalantri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. K. C. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harinath, B.C., Reddy, M.V.R., Alli, R. et al. Immunomonitoring followed by optimal dec therapy for successful management of clinical filariasis in an endemic area. Indian J Clin Biochem 14, 100–108 (1999). https://doi.org/10.1007/BF02867907

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02867907

Key words

Search

Navigation